/KDEVF
KDEVF Stock - Karolinska Development AB (publ)
Healthcare|BiotechnologyOTC
$0.26+0.00%
+$0.00 (+0.00%) • Jun 22
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.28
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for KDEVF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.26 – $0.26
TARGET (TP)$0.30
STOP LOSS$0.24
RISK/REWARD1:2.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.24
52W High$0.61
52W Low$0.26
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $2.81M | $2.30M | $2.17M | $2.65M | $3.38M |
| Gross Profit | $2.81M | $2.30M | $2.17M | $2.65M | $3.38M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $-1,911,000 | $-87,421,000 | $160.70M | $-202,426,000 | $347.94M |
| Net Income | $5.39M | $-88,122,000 | $170.82M | $-207,487,000 | $302.98M |
| Net Margin | 191.9% | -3831.4% | 7871.8% | -7826.7% | 8953.2% |
| EPS | $0.02 | $-0.34 | $0.86 | $-1.05 | $3.63 |
Company Overview
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
KDEVFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2024
EPS Surprise History
Q1 23
No data
Q1 23
No data
Q2 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Nov 15, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 26, 2024 | — | $0.00 | — | — |
Q1 2024 | Feb 16, 2024 | — | $0.00 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q1 2023 | Feb 17, 2023 | — | $0.00 | — | — |
Q4 2022 | Nov 18, 2022 | — | $-0.02 | — | — |
Q3 2022 | Aug 19, 2022 | — | $-0.01 | — | — |
Q2 2022 | Apr 29, 2022 | — | $-0.01 | — | — |
Q1 2022 | Feb 25, 2022 | — | $-0.01 | — | — |
Q4 2021 | Nov 18, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 19, 2021 | — | $0.14 | — | — |
Q2 2021 | Apr 29, 2021 | — | $-0.02 | — | — |
Q1 2021 | Feb 11, 2021 | — | $0.05 | — | — |
Q4 2020 | Nov 11, 2020 | — | $-0.10 | — | — |
Q3 2020 | Aug 20, 2020 | — | $0.00 | — | — |
Q2 2020 | Apr 30, 2020 | — | $-0.06 | — | — |
Q1 2020 | Feb 13, 2020 | — | $0.31 | — | — |
Latest News
Loading news...
Frequently Asked Questions about KDEVF
What is KDEVF's current stock price?
Karolinska Development AB (publ) (KDEVF) is currently trading at $0.26 per share. The stock has moved +0.00% today.
What is the analyst price target for KDEVF?
No analyst price targets are currently available for this stock.
What sector is Karolinska Development AB (publ) in?
Karolinska Development AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is KDEVF's market cap?
Karolinska Development AB (publ) has a market capitalization of $0.07 billion, making it a small-cap company.
Does KDEVF pay dividends?
No, Karolinska Development AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBSTG
Biostage, Inc.
$4.03
Mkt Cap: $0.1B
EOFBY
Ecofibre Limited
$0.84
Mkt Cap: $0.1B
ETXPF
E-therapeutics Plc
$0.13
Mkt Cap: $0.1B
HRPMF
Herantis Pharma Oyj
$3.51
Mkt Cap: $0.1B
KIARF
Kiaro Holdings Corp.
$0.00
Mkt Cap: $0.0B
MSSTF
Mindset Pharma Inc.
$0.54
Mkt Cap: $0.1B
MVRBF
Medivir AB (publ)
$0.82
Mkt Cap: $0.0B
NEVPF
Abliva AB (publ)
$0.03
Mkt Cap: $0.0B
ONPPF
Oncopeptides AB (publ)
$0.27
Mkt Cap: $0.1B
SYMQY
SymBio Pharmaceuticals Limited
$0.64
Mkt Cap: $0.0B
Explore stocks similar to KDEVF for comparison